Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543381
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML MDS or CMML After Donor Hematopoietic Cell Transplant
Sponsor:
Organization:
None